Testing for Sexually Transmitted and Bloodborne Infections in Substance Users: Insights from the 2023 British Columbia Harm Reduction Client Survey - Quiz - MDSpire

Testing for Sexually Transmitted and Bloodborne Infections in Substance Users: Insights from the 2023 British Columbia Harm Reduction Client Survey

  • By

  • Amrit Tiwana

  • Katherine A. Twohig

  • Mieke Fraser

  • Brooke Kinniburgh

  • Charlene Burmeister

  • Paul Choisil

  • Elizabeth Haywood

  • Dylan Griffith

  • Chloé G. Xavier

  • Alannah Hannigan

  • Kate Salters

  • Sofia R. Bartlett

  • February 23, 2026

  • 0 min

Share

Original Source(s)

Testing for Sexually Transmitted and Bloodborne Infections in Substance Users: Insights from the 2023 British Columbia Harm Reduction Client Survey

  • by Amrit Tiwana, Katherine A. Twohig, Mieke Fraser, Brooke Kinniburgh, Charlene Burmeister, Paul Choisil, Elizabeth Haywood, Dylan Griffith, Chloé G. Xavier, Alannah Hannigan, Kate Salters, Sofia R. Bartlett

  • February 23, 2026

Related Content

How Language Shapes Care 

ACP examines ethical implications of calling all physicians “providers”

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.